Tags » Daiichi Sankyo

Did US Attorney's Subpoenas Push Daiichi Sankyo to Finally Dump Ranbaxy?

Japan’sĀ Daiichi Sankyo is selling off troubled India-based drug maker Ranbaxy, and recent moves by the New Jersey U.S. Attorney’s Office may have helped tipped the move. 131 more words

Daiichi Sankyo's Ranbaxy sell-off highlights the pitfalls of making drugs in India

Nearly six years after taking a controlling stake in India’s Ranbaxy Laboratories, Japanese pharmaceutical company Daiichi Sankyo hasĀ thrown in the towel, selling its stake to Sun Pharmaceuticals for $3.2 billion in stock. 404 more words